Search Results

There are 13849 results for: content related to: Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial

  1. You have free access to this content
    Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients

    Intervention Review

    The Cochrane Library

    Elisabeth M Hodson, Maleeka Ladhani, Angela C Webster, Giovanni FM Strippoli and Jonathan C Craig

    Published Online : 28 FEB 2013, DOI: 10.1002/14651858.CD003774.pub4

  2. Prevention and treatment of cytomegalovirus infection in organ transplant recipients

    Transplant Infectious Disease

    Volume 1, Issue 3, September 1999, Pages: 187–203, S. Kusne, R. Shapiro and J. Fung

    Version of Record online : 5 JAN 2002, DOI: 10.1034/j.1399-3062.1999.010307.x

  3. You have free access to this content
    Cytomegalovirus

    American Journal of Transplantation

    Volume 4, Issue s10, October 2004, Pages: 51–58,

    Version of Record online : 25 OCT 2004, DOI: 10.1111/j.1600-6135.2004.00727.x

  4. Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: prevention and therapy

    Transplant Infectious Disease

    Volume 1, Issue 3, September 1999, Pages: 165–178, M. Boeckh

    Version of Record online : 5 JAN 2002, DOI: 10.1034/j.1399-3062.1999.010305.x

  5. You have free access to this content
    Cytomegalovirus in Solid Organ Transplantation

    American Journal of Transplantation

    Volume 13, Issue s4, March 2013, Pages: 93–106, R. R. Razonable, A. Humar and the AST Infectious Diseases Community of Practice

    Version of Record online : 6 MAR 2013, DOI: 10.1111/ajt.12103

  6. The Role of Ganciclovir in Transplantation

    Immunotherapy in Transplantation: Principles and Practice

    Lyndsey J. Bowman, Daniel C. Brennan, Pages: 316–329, 2012

    Published Online : 19 APR 2012, DOI: 10.1002/9781444355628.ch21

  7. Prevention dof recurrent cytomegalovirus disease in renal and liver transplant recipients: effect of oral ganciclovir

    Transplant Infectious Disease

    Volume 2, Issue 1, March 2000, Pages: 2–10, N. Turgeon, J.A. Fishman, M. Doran, N. Basgoz, N.E. Tolkoff-Rubin, A.B. Cosimi and R.H. Rubin

    Version of Record online : 25 DEC 2001, DOI: 10.1034/j.1399-3062.2000.020102.x

  8. Cytomegalovirus Infection

    Thomas' Hematopoietic Cell Transplantation, Third Edition

    Karl G. Blume, Stephen J. Forman, Frederick R. Appelbaum, Pages: 701–726, 2007

    Published Online : 26 OCT 2007, DOI: 10.1002/9780470987070.ch53

  9. Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation

    Internal Medicine Journal

    Volume 34, Issue 3, March 2004, Pages: 98–101, J. Szer, 1 S. Durrant, 2 A. P. Schwarer, 3 K. F. Bradstock, 4 J. Gibson, 5 C. Arthur, 6 L. B. To, 7 T. Hughes and 7 H. Raunow 1,8

    Version of Record online : 25 MAR 2004, DOI: 10.1111/j.1444-0903.2004.00550.x

  10. Treatment and Prophylaxis of Cytomegalovirus Disease

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 12, Issue 4, July-August 1992, Pages: 300–318, Miriam L. Levinson and Pamala A. Jacobson

    Version of Record online : 24 FEB 2012, DOI: 10.1002/j.1875-9114.1992.tb04464.x

  11. Low incidence of cytomegalovirus disease in liver transplant recipients receiving sirolimus primary immunosuppression with 3-day corticosteroid taper

    Transplant Infectious Disease

    Volume 5, Issue 4, December 2003, Pages: 174–180, J.F. Trotter, A. Wallack and T. Steinberg

    Version of Record online : 27 FEB 2004, DOI: 10.1111/j.1399-3062.2003.00032.x

  12. You have free access to this content
    Cytomegalovirus in Solid Organ Transplant Recipients

    American Journal of Transplantation

    Volume 9, Issue s4, December 2009, Pages: S78–S86, A. Humar, D. Snydman and the AST Infectious Diseases Community of Practice

    Version of Record online : 16 DEC 2009, DOI: 10.1111/j.1600-6143.2009.02897.x

  13. You have free access to this content
    Retrospective review of the incidence of cytomegalovirus infection and disease after liver transplantation in pediatric patients: Comparison of prophylactic oral ganciclovir and oral valganciclovir

    Liver Transplantation

    Volume 18, Issue 3, March 2012, Pages: 347–354, Ashley N. Bedel, Trina S. Hemmelgarn and Rohit Kohli

    Version of Record online : 24 FEB 2012, DOI: 10.1002/lt.22471

  14. You have free access to this content
    Intravenous ganciclovir prophylaxis for cytomegalovirus in heart, heart-lung, and lung transplant recipients

    Transplant International

    Volume 12, Issue 4, July 1999, Pages: 254–260, T.G. Wreghitt, S.J.C. Abel, K. McNeil, J. Parameshwar, L. Sharpies, S. Large, J. Wallwork, S. Stewart and N. Cary

    Version of Record online : 2 JUN 2008, DOI: 10.1111/j.1432-2277.1999.tb01210.x

  15. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis

    Transplant Infectious Disease

    Volume 2, Issue 3, September 2000, Pages: 112–117, R.H. Rubin, S.A. Kemmerly, D. Conti, M. Doran, B.M. Murray, J.F. Neylan, C. Pappas, D. Pitts, R. Avery, M. Pavlakis, R. Del Busto, D. DeNofrio, E.A. Blumberg, D.A. Schoenfeld, T. Donohue, S.A. Fisher and J.A. Fishman

    Version of Record online : 9 OCT 2008, DOI: 10.1111/j.1399-3062.2000.020303.x

  16. You have free access to this content
    Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients

    American Journal of Transplantation

    Volume 4, Issue 4, April 2004, Pages: 611–620, Carlos Paya, Atul Humar, Ed Dominguez, Kenneth Washburn, Emily Blumberg, Barbara Alexander, Richard Freeman, Nigel Heaton, Mark D. Pescovitz and Valganciclovir Solid Organ Transplant Study Group

    Version of Record online : 25 FEB 2004, DOI: 10.1111/j.1600-6143.2004.00382.x

  17. Cytomegalovirus

    Principles and Practice of Clinical Virology, Fifth Edition

    Arie J. Zuckerman, Jangu E. Banatvala, John R. Pattison, Paul D. Griffiths, Barry D. Schoub, Pages: 85–122, 2004

    Published Online : 21 JUL 2004, DOI: 10.1002/0470020970.ch2C

  18. You have free access to this content
    Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation

    British Journal of Haematology

    Volume 111, Issue 3, December 2000, Pages: 782–790, Karl S. Peggs, Wolfgang Preiser, Panagiotis D. Kottaridis, Nikki McKeag, Nicola S. Brink, Richard S. Tedder, Anthony H. Goldstone, David C. Linch and Stephen Mackinnon

    Version of Record online : 2 AUG 2008, DOI: 10.1111/j.1365-2141.2000.02419.x

  19. Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients

    Intervention Review

    The Cochrane Library

    Elisabeth M Hodson, Cheryl A Jones, Giovanni FM Strippoli, Angela C Webster and Jonathan C Craig

    Published Online : 18 APR 2007, DOI: 10.1002/14651858.CD005129.pub2

  20. Prevention of infections in solid organ transplant recipients

    Transplant Infectious Disease

    Volume 1, Issue 1, March 1999, Pages: 50–64, Jorge S. Villacian and Carlos V. Paya

    Version of Record online : 5 JAN 2002, DOI: 10.1034/j.1399-3062.1999.10106.x